Schoonbroodt Sonia, Ichanté Jean-Laurent, Boffé Sophie, Devos Nathalie, Devaster Jeanne-Marie, Taddei Laura, Rondini Simona, Arora Ashwani Kumar, Pascal Thierry, Malvaux Ludovic
GSK, Rixensart, Belgium.
GSK, Wavre, Belgium.
Front Microbiol. 2023 Feb 24;13:1098133. doi: 10.3389/fmicb.2022.1098133. eCollection 2022.
We compared the performance of real-time PCR with culture-based methods for identifying bacteria in sputum samples from patients with chronic obstructive pulmonary disease (COPD) in three studies.
This was an exploratory analysis of sputum samples collected during an observational study of 127 patients (AERIS; NCT01360398), phase 2 study of 145 patients (NTHI-004; NCT02075541), and phase 2b study of 606 patients (NTHI-MCAT-002; NCT03281876). Bacteria were identified by culture-based microbiological methods in local laboratories using fresh samples or by real-time PCR in a central laboratory using frozen samples. positivity with culture was differentiated from positivity by microarray analysis or PCR. The feasibility of bacterial detection by culture-based methods on previously frozen samples was also examined in the NTHI-004 study.
Bacterial detection results from both culture-based and PCR assays were available from 2,293 samples from AERIS, 974 from the NTHI-004 study, and 1736 from the NTHI-MCAT-002 study. Quantitative real-time PCR (qPCR) showed higher positivity rates than culture for (percentages for each study: 43.4% versus 26.2%, 47.1% versus 23.6%, 32.7% versus 10.4%) and (12.9% versus 6.3%, 19.0% versus 6.0%, 15.5% versus 4.1%). In the NTHI-004 and NTHI-MCAT-002 studies, positivity rates were higher with qPCR for (15.6% versus 6.1%, 15.5% versus 3.8%); in AERIS, a lower rate with qPCR than with culture (11.0% versus 17.4%) was explained by misidentification of isolates conventional microbiological methods. Concordance analysis showed lowest overall agreement for (82.0%, 75.6%, 77.6%), due mainly to culture-negative/qPCR-positive samples, indicating lower sensitivity of the culture-based methods. The lowest positive agreement (culture-positive/qPCR-positive samples) was observed for (35.1%, 71.2%, 71.2%). Bacterial load values for each species showed a proportion of culture-negative samples with a load detected by qPCR; for some samples, the loads were in line with those observed in culture-positive samples. In the NTHI-004 study, of fresh samples that tested culture-positive, less than 50% remained culture-positive when tested from freeze/thawed samples. In the NTHI-004 study, of fresh samples that tested culture-positive, less than 50% remained culture-positive when tested from freeze/thawed samples.
Real-time PCR on frozen sputum samples has enhanced sensitivity and specificity over culture-based methods, supporting its use for the identification of common respiratory bacterial species in patients with COPD.
在三项研究中,我们比较了实时荧光定量聚合酶链反应(real-time PCR)与基于培养的方法在慢性阻塞性肺疾病(COPD)患者痰液样本中鉴定细菌的性能。
这是对在一项针对127例患者的观察性研究(AERIS;NCT01360398)、一项针对145例患者的2期研究(NTHI - 004;NCT02075541)以及一项针对606例患者的2b期研究(NTHI - MCAT - 002;NCT03281876)期间收集的痰液样本进行的探索性分析。细菌通过当地实验室使用新鲜样本的基于培养的微生物学方法进行鉴定,或通过中央实验室使用冷冻样本的实时荧光定量聚合酶链反应进行鉴定。通过微阵列分析或聚合酶链反应区分培养阳性与其他阳性情况。在NTHI - 004研究中还检测了基于培养的方法对先前冷冻样本进行细菌检测的可行性。
来自AERIS的2293份样本、NTHI - 004研究的974份样本以及NTHI - MCAT - 002研究的1736份样本均获得了基于培养和聚合酶链反应检测的细菌结果。定量实时荧光定量聚合酶链反应(qPCR)显示,对于[具体细菌1](每项研究的百分比:43.4%对26.2%,47.1%对23.6%,32.7%对10.4%)和[具体细菌2](12.9%对6.3%,19.0%对6.0%,15.5%对4.1%),其阳性率高于培养法。在NTHI - 004和NTHI - MCAT - 002研究中,对于[具体细菌3],qPCR的阳性率更高(15.6%对6.1%,15.5%对3.8%);在AERIS中,qPCR的阳性率低于培养法(11.0%对17.4%),这是由于传统微生物学方法对[具体细菌4]分离株的错误鉴定所致。一致性分析显示,对于[具体细菌5],总体一致性最低(82.0%,75.6%,77.6%),主要原因是培养阴性/qPCR阳性样本,表明基于培养的方法敏感性较低。观察到对于[具体细菌6],阳性一致性最低(培养阳性/qPCR阳性样本)(35.1%,71.2%,71.2%)。每个菌种的细菌载量值显示,一部分培养阴性样本通过qPCR检测到有载量;对于一些样本,载量与培养阳性样本中观察到的载量一致。在NTHI - 004研究中,新鲜样本培养阳性的,经冻融样本检测时,不到50%仍保持培养阳性。在NTHI - 004研究中,新鲜样本培养阳性的,经冻融样本检测时,不到50%仍保持培养阳性。
对冷冻痰液样本进行实时荧光定量聚合酶链反应比基于培养的方法具有更高的敏感性和特异性,支持其用于鉴定COPD患者常见的呼吸道细菌菌种。